Engineering Employer: Alnylam    « Engineering Employers

Alnylam Pharmaceuticals: Alnylam Pharmaceuticals develops and commercializes novel therapeutics based on RNA interference (RNAi). The company's lead RNAi therapeutic program includes ALN-RSV01, a phase II clinical trial product for the treatment of respiratory syncytial virus (RSV) infections.